NCT01765907View on ClinicalTrials.gov

Antalgic Treatment of Painful Bone Metastases by US-guided High Intensity Focused Ultrasound (HIFU)

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Bone Metastasis
Interventions
DEVICE

HIFU

Trial Locations (1)

94275

Institut Gustave Roussy, Villejuif

Sponsors

Lead Sponsor

Theraclion
All Listed Sponsors
lead

Theraclion

INDUSTRY

NCT01765907 - Antalgic Treatment of Painful Bone Metastases by US-guided High Intensity Focused Ultrasound (HIFU) | Biotech Hunter | Biotech Hunter